Liver Transplantation in Well-Selected Class III Obese Recipients Yields Good Outcomes

被引:0
|
作者
Yi, Kevin [1 ,2 ]
Avery, Vicki [1 ]
Mccall, John [1 ,2 ]
Giles, Hannah [1 ,2 ]
Lindsay, Helen [3 ]
Gane, Ed [1 ,2 ]
Orr, David [1 ]
Barbier, Louise [1 ,2 ]
机构
[1] Auckland City Hosp, New Zealand Liver Transplant Unit, Te Toka Tumai, Auckland, New Zealand
[2] Univ Auckland, Dept Surg, Auckland, New Zealand
[3] Auckland City Hosp, Anesthesia & Perioperat Care, Te Toka Tumai, Auckland, New Zealand
关键词
liver transplantation; metabolic syndrome; obesity; outcomes; CORONARY-ARTERY-DISEASE; ASSOCIATION; GUIDELINE; MORTALITY; INDEX;
D O I
10.1111/ctr.70060
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: Previous guidelines considered body mass index (BMI) over 40 kg/m(2) a relative contra-indication to liver transplantation (LT). The aims were to examine the selection process and study outcomes of patients with Class I-III obesity. Methods: Retrospective analysis of outcomes of obese patients assessed for LT at our center between 2010 and 2023, divided into three groups: Class I (BMI30-34.9 kg/m(2)), Class II (BMI35-39.9 kg/m(2)), and Class III (BMI>40 kg/m(2)). Survival of non-obese adult patients was used for comparison. Results: Three hundred fifteen patients with BMI >= 30 kg/m(2) were assessed for LT. Seventeen (5.4%) were not wait-listed due to comorbidities. One hundred sixty-eight patients were transplanted: 100 Class I, 43 Class II, and 25 Class III. There were no differences in postoperative complications (Clavien-Dindo Grade 3 or more; 41%, 42%, 48% for Class I-III obesity respectively) or patient and graft survival (5-y rates 84.4% and 82.7%, respectively, for the whole cohort) according to the different classes of obesity. Furthermore, patient and graft survival was not different between non-obese and obese patients (p = 0.932). Conclusion: With a rigorous selection process, short-term outcomes after LT for patients with Class III obesity were comparable to patients with Class I-II obesity. Long-term survival was identical for obese and non-obese patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] A comparison of outcomes between class-II and class-III obese patients undergoing robotic ventral hernia repair: a multicenter study
    Kudsi, O. Y.
    Gokcal, F.
    Bou-Ayash, N.
    Watters, E.
    Pereira, X.
    Lima, D. L.
    Malcher, F.
    HERNIA, 2022, 26 (06) : 1531 - 1539
  • [32] Propensity Score-Matched Analysis of Posttransplant Outcomes in Living Donor Liver Transplantation for Older Adult Recipients
    Hakeem, Abdul Rahman
    Fathima, Rukhaiya
    Padmanaban, Hrishikesh
    Haribabu, Kulaseharan
    Rajalingam, Rajesh
    Palaniappan, Kumar
    Jothimani, Dinesh
    Kanagavelu, Rathan
    Rajakumar, Akila
    Kaliamoorthy, Ilankumaran
    Reddy, Mettu Srinivas
    Rela, Mohamed
    LIVER TRANSPLANTATION, 2021, 27 (09) : 1273 - 1282
  • [33] Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients
    Locke, Jayme E.
    Durand, Christine
    Reed, Rhiannon D.
    MacLennan, Paul A.
    Mehta, Shikha
    Massie, Allan
    Nellore, Anoma
    DuBay, Derek
    Segev, Dorry L.
    TRANSPLANTATION, 2016, 100 (01) : 141 - 146
  • [34] Germany's first robot-assisted kidney transplantation from a deceased donor: a good option in obese recipients-with the right team
    Reimold, Philipp
    Groeben, Christer
    Keil, Christian
    Kormann, Fabian
    Peters, Liliane
    Volberg, Christian
    Kortus-Goetze, Birgit
    Wild, Johannes
    Hoyer, Joachim
    Flegar, Luka
    Huber, Johannes
    UROLOGIE, 2024, : 1266 - 1270
  • [35] Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit
    Su, Feng
    Yu, Lei
    Berry, Kristin
    Liou, Iris W.
    Landis, Charles S.
    Rayhill, Stephen C.
    Reyes, Jorge D.
    Ioannou, George N.
    GASTROENTEROLOGY, 2016, 150 (02) : 441 - +
  • [36] Comparison of hepatitis B prophylactic outcomes in living donor liver transplantation recipients who meet the Milan or UCSF criteria
    Li Jiang
    Lu-Nan Yan
    Tian-Fu Wen
    Bo Li
    Jia-Yin Yang
    Hepatobiliary&PancreaticDiseasesInternational, 2013, 12 (05) : 494 - 499
  • [37] Association between non-alcoholic fat liver disease and liver function/injury markers with metabolic syndrome components in class III obese individuals
    Chaves, Gabriela Villaca
    de Souza, Daiane Spitz
    Pereira, Silvia Elaine
    Saboya, Carlos Jose
    Ferreira Peres, Wilza Arantes
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2012, 58 (03): : 288 - 293
  • [38] Impact of CYP3A5 genotype of recipients as well as donors on the tacrolimus pharmacokinetics and infectious complications after living-donor liver transplantation for Japanese adult recipients
    Muraki, Yuichi
    Usul, Masanobu
    Isaji, Shuji
    Mizuno, Shugo
    Nakatani, Kaname
    Yamada, Tomomi
    Iwamoto, Takuya
    Uemoto, Shinji
    Nobori, Tsutomu
    Okuda, Masahiro
    ANNALS OF TRANSPLANTATION, 2011, 16 (04) : 55 - 62
  • [39] Characteristics and Outcomes of Liver Transplantation Recipients after Tranexamic Acid Treatment and Platelet Transfusion: A Retrospective Single-Centre Experience
    Alsabani, Mohmad H.
    Sibai, Abdulrazak
    Alharbi, Saja F.
    Olayan, Lafi H.
    Samman, Abeer A.
    Al Harbi, Mohammed K.
    MEDICINA-LITHUANIA, 2023, 59 (02):
  • [40] A Meta-Analysis and Systematic Review on the Global Prevalence, Risk Factors, and Outcomes of Coronary Artery Disease in Liver Transplantation Recipients
    Xiao, Jieling
    Yong, Jie Ning
    Ng, Cheng Han
    Syn, Nicholas
    Lim, Wen Hui
    Tan, Darren Jun Hao
    Tan, En Ying
    Huang, Daniel
    Wong, Raymond C.
    Chew, Nicholas W. S.
    Tan, Eunice Xiang Xuan
    Noureddin, Mazen
    Siddiqui, Mohammad Shadab
    Muthiah, Mark D.
    LIVER TRANSPLANTATION, 2022, 28 (04) : 689 - 699